Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
14%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
PBE
27
HOLDINGS
30%
ALSO IN PSCH
PSCH
71
HOLDINGS
11%
ALSO IN PBE
SECTOR DRIFT (PBE minus PSCH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in PSCH |
Overlap | |
---|---|---|---|---|
PROTAGONIST THERAPEUTICS, INC. | 3.1% | 2.4% | 2.4% | |
ACADIA PHARMACEUTICALS INC | 3.0% | 2.2% | 2.2% | |
TG THERAPEUTICS INC | 2.1% | 2.7% | 2.1% | |
ARROWHEAD PHARMACEUTICALS, INC. | 3.5% | 1.8% | 1.8% | |
VERACYTE INC | 2.8% | 1.7% | 1.7% |
PBE Overweight Relative to PSCH
ALNYLAM PHARMACEUTICALS INC | 7.4% | |
ILLUMINA INC | 5.8% | |
ROYALTY PHARMA PLC CLASS A | 5.3% | |
GILEAD SCIENCES INC | 5.2% | |
AMGEN INC | 5.1% | |
UNITED THERAPEUTICS CORP | 4.7% | |
BIOMARIN PHARMACEUTICAL INC | 4.7% | |
VERTEX PHARMACEUTICALS INC | 4.2% | |
ANAVEX LIFE SCIENCES CORP. | 3.5% | |
INCYTE CORP | 3.5% |
PBE Underweight Relative to PSCH
CORCEPT THERAPEUTICS INC | -4.8% | |
TELEFLEX INC | -3.8% | |
GLAUKOS CORP | -3.6% | |
MERIT MEDICAL SYSTEMS INC | -3.6% | |
ALKERMES PLC | -3.4% | |
RADNET INC | -3.2% | |
TRANSMEDICS GROUP, INC. | -3.0% | |
ADMA BIOLOGICS, INC. | -2.9% | |
KRYSTAL BIOTECH, INC. | -2.7% | |
INTEGER HOLDINGS CORPORATION | -2.6% |